Affinity DataIC50: 4nMAssay Description:Inhibition of [3H]rolipram binding to Phosphodiesterase 4 (PDE IV)More data for this Ligand-Target Pair
3D Structure (crystal)Affinity DataIC50: 4nMAssay Description:Displacement of [3H]-Rolipram from mouse brain homogenatesMore data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Displacement of [3H]-Rolipram from mouse brain homogenatesMore data for this Ligand-Target Pair
Affinity DataIC50: 78nMAssay Description:Displacement of [3H]-Rolipram from mouse brain homogenatesMore data for this Ligand-Target Pair
Affinity DataIC50: 130nMAssay Description:Displacement of [3H]-Rolipram from mouse brain homogenatesMore data for this Ligand-Target Pair
Affinity DataIC50: 220nMAssay Description:Displacement of [3H]-Rolipram from mouse brain homogenatesMore data for this Ligand-Target Pair
Affinity DataIC50: 620nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 650nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 670nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 700nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 700nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 750nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 810nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 860nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 900nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 900nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 930nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 980nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
